{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:45:57Z","timestamp":1793907957342,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cmi.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T17:10:59Z","timestamp":1523898659000},"page":"1234-1240","source":"Crossref","is-referenced-by-count":100,"title":["Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"T.A.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Manz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Fingerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pfirrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Koedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.04.007_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis\u2014epidemiology, diagnosis and management","volume":"11","author":"Koedel","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.cmi.2018.04.007_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cmi.2018.04.007_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QCO.0000000000000332","article-title":"Lyme neuroborreliosis","volume":"30","author":"Koedel","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2018.04.007_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","article-title":"CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity","volume":"16","author":"Ansel","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.cmi.2018.04.007_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(02)00233-X","article-title":"Lymphocyte traffic control by chemokines: follicular B helper T cells","volume":"85","author":"Moser","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cmi.2018.04.007_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000171349.06645.79","article-title":"The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis","volume":"65","author":"Rupprecht","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2018.04.007_bib7","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1128\/IAI.01642-06","article-title":"Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2","volume":"75","author":"Rupprecht","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2018.04.007_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-6-42","article-title":"The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis","volume":"6","author":"Rupprecht","year":"2009","journal-title":"J\u00a0Neuroinflamm"},{"key":"10.1016\/j.cmi.2018.04.007_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.60.6.849","article-title":"The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis","volume":"60","author":"Cepok","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cmi.2018.04.007_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00115-005-2021-7","article-title":"Cytokine CXCL13\u2014a possible early CSF marker for neuroborreliosis","volume":"77","author":"Rupprecht","year":"2006","journal-title":"Nervenarzt"},{"key":"10.1016\/j.cmi.2018.04.007_bib11","first-page":"732","article-title":"CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis","volume":"255","author":"Ljostad","year":"2008","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cmi.2018.04.007_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-13-2","article-title":"Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection","volume":"13","author":"Bremell","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.cmi.2018.04.007_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","article-title":"The chemokine CXCL13 in acute neuroborreliosis","volume":"81","author":"Senel","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cmi.2018.04.007_bib14","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid","volume":"49","author":"van Burgel","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2018.04.007_bib15","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/CVI.00353-13","article-title":"Diagnostic value of cytokines and chemokines in Lyme neuroborreliosis","volume":"20","author":"Cerar","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2018.04.007_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","volume":"9","author":"Kowarik","year":"2012","journal-title":"J\u00a0Neuroinflamm"},{"key":"10.1016\/j.cmi.2018.04.007_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Hytonen","year":"2014","journal-title":"J\u00a0Neuroinflamm"},{"key":"10.1016\/j.cmi.2018.04.007_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2018.04.007_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12874-016-0196-1","article-title":"Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies","volume":"16","author":"Steinhauser","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cmi.2018.04.007_bib20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cmi.2018.04.007_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1469-0691.12474","article-title":"Systematic reviews and meta-analyses of diagnostic test accuracy","volume":"20","author":"Leeflang","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2018.04.007_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","author":"Freeman","year":"1950","journal-title":"Ann Math Stat"},{"key":"10.1016\/j.cmi.2018.04.007_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trial"},{"key":"10.1016\/j.cmi.2018.04.007_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cmi.2018.04.007_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/jir.2016.0101","article-title":"Chemokine CXC ligand 13 in cerebrospinal fluid can be used as an early diagnostic biomarker for Lyme neuroborreliosis: a meta-analysis","volume":"37","author":"Yang","year":"2017","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.cmi.2018.04.007_bib26","first-page":"149","article-title":"Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis","volume":"62","author":"Tjernberg","year":"2011","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2018.04.007_bib27","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1097\/INF.0000000000001669","article-title":"Cerebrospinal fluid B-lymphocyte chemoattractant CXCL 13 in the diagnosis of acute Lyme neuroborreliosis in children","volume":"36","author":"Barstad","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2018.04.007_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12974-017-0789-6","article-title":"Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study","volume":"14","author":"Gyllemark","year":"2017","journal-title":"J\u00a0Neuroinflamm"},{"key":"10.1016\/j.cmi.2018.04.007_bib29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jns.2016.05.059","article-title":"Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections","volume":"368","author":"Picha","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.cmi.2018.04.007_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12974-017-0948-9","article-title":"Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study","volume":"14","author":"Remy","year":"2017","journal-title":"J\u00a0Neuroinflamm"},{"key":"10.1016\/j.cmi.2018.04.007_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00115-014-4020-z","article-title":"CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine","volume":"85","author":"Rupprecht","year":"2014","journal-title":"Nervenarzt"},{"key":"10.1016\/j.cmi.2018.04.007_bib32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","article-title":"A\u00a0prospective study on the role of CXCL13 in Lyme neuroborreliosis","volume":"76","author":"Schmidt","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2018.04.007_bib33","first-page":"74","article-title":"CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients","volume":"265","author":"Wagner","year":"2018","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cmi.2018.04.007_bib34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00115-017-0292-4","article-title":"CXCL-13 as a biomarker in the diagnostics of neuroborreliosis","volume":"88","author":"Waiss","year":"2017","journal-title":"Nervenarzt"},{"key":"10.1016\/j.cmi.2018.04.007_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0404.2010.01477.x","article-title":"CXCL13 chemokine in pediatric and adult neuroborreliosis","volume":"124","author":"Wutte","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.cmi.2018.04.007_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/OLQ.0b013e3181d877a1","article-title":"CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis","volume":"37","author":"Marra","year":"2010","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.cmi.2018.04.007_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/0956462415577229","article-title":"Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients","volume":"27","author":"Hu","year":"2016","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.cmi.2018.04.007_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12987-015-0008-8","article-title":"The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis","volume":"12","author":"Dersch","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.cmi.2018.04.007_bib39","doi-asserted-by":"crossref","first-page":"33569","DOI":"10.1038\/srep33569","article-title":"CXCL13, CXCL10 and CXCL8 as potential biomarkers for the diagnosis of neurosyphilis patients","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2018.04.007_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s40064-016-2462-4","article-title":"CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients","volume":"5","author":"Zeng","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.cmi.2018.04.007_bib41","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1182\/blood-2013-01-476333","article-title":"CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma","volume":"121","author":"Rubenstein","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2018.04.007_bib42","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.45.9.1663","article-title":"Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis","volume":"45","author":"Tumani","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2018.04.007_bib43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1468-1331.2010.03229.x","article-title":"The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis\u2014the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic","volume":"18","author":"Djukic","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cmi.2018.04.007_bib44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1468-1331.2007.01799.x","article-title":"Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis","volume":"14","author":"Ljostad","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cmi.2018.04.007_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040909","article-title":"Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness","volume":"7","author":"Tiberti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2018.04.007_bib46","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1158\/1078-0432.CCR-09-0108","article-title":"CXCL13 and CXCL12 in central nervous system lymphoma patients","volume":"15","author":"Fischer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cmi.2018.04.007_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1155\/2009\/704292","article-title":"Retrospective studies","volume":"16","author":"Anthonisen","year":"2009","journal-title":"Can Respir J"},{"key":"10.1016\/j.cmi.2018.04.007_bib48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jneumeth.2013.03.011","article-title":"Pre-analytical factors influencing the stability of cerebrospinal fluid proteins","volume":"215","author":"Simonsen","year":"2013","journal-title":"J\u00a0Neurosci Methods"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18303422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18303422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T20:44:29Z","timestamp":1660941869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18303422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1198743X18303422"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.04.007","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}